Insurers are uncertain over the fate of cost-sharing reduction subsidies and that is expected to be reflected in prices next year. » Read More
By: Kayla Tausche
Uncertainty over the cost-sharing subsidies have led to higher price hikes for Obamacare plans next year in some states already. » Read More
By: Dylan Scott
If conservatives can't change Obamacare's insurance rules, it could put the whole repeal-and-replace effort in jeopardy, Vox reports. » Read More
By: Leslie Shaffer
Trump’s budget proposal will include massive cuts to Medicaid and other anti-poverty programs, the Washington Post reported, citing sources. » Read More
Mylan last fall agreed to pay $465 million to resolve claims it shortchanged Medicaid, but got a six-month grace period on higher rebates.
While the White House and Congress struggled to repeal Obamacare, investors did not shy away from health-care stocks in the first quarter.
Evidence is mixed on why health insurance hasn't lead to better health in the U.S., Vox reports.
While our politicians dither over reform, here are effective business solutions to reining in health-care costs, says Richard L. Jackson.
According to a filing from the U.S. Patent and Trademark Office, Forward Pharma has been interfering with Biogen.
Republicans have been unable to get their House caucus to agree on an Obamacare replacement that can win enough votes to go to the Senate.
Collins' comments come as the president is seeking major budget cuts at NIH, the nation's engine for scientific and medical research.
Former Clinton Treasury Secretary Larry Summers points to a variety of clouds over the presidency of Donald Trump.
The stock was upgraded in anticipation of positive data from upcoming product trials.
A vote on the bill was cancelled last Friday in the House after a handful of Republicans said they would oppose the bill.
Republicans who want Obamacare repealed and replaced are faced with concerns about how to do so from the right, and the left, in Congress.
"I am committed to fulfilling the oath that I took, which is upholding the law of the land," Health and Human Services Secretary Tom Price said.
The track record in drug development for Alzheimer's disease has been terrible: a success rate of less than 1 percent.
Obamacare is still the law of the land but here are the big challenges it faces now, says PolicyGenius CEO Jennifer Fitzgerald.
A rural and urban divide, along with racial differences, were also evident in a new report on drug overdoses, USA Today reports.
Drugmakers may soon face renewed pressure on high prices, now that Republicans have pulled their American Health Care Act, Citi says.
Researchers say this is the first time a device has restored this much arm movement in a person with a chronic spinal cord injury.
Ackman's Pershing Square Holdings saw returns for its main fund tumble 13.5 percent net of fees in 2016.
Kansas Gov. Sam Brownback is expected to veto expansion of Medicaid in Kansas.
The GOP health-care bill's defeat removes uncertainty for insurers as they prep 2018 rates, but unresolved legal issues remain.
Get the best of CNBC in your inbox